ACR Share Price

Open 0.15 Change Price %
High 0.15 1 Day 0.00 0.00
Low 0.14 1 Week -0.01 -6.25
Close 0.15 1 Month -0.11 -42.31
Volume 365518 1 Year -0.19 -55.88
52 Week High 0.38
52 Week Low 0.14
ACR Important Levels
Resistance 2 0.16
Resistance 1 0.16
Pivot 0.15
Support 1 0.14
Support 2 0.14
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
LYC 0.18 -5.26%
TLS 3.53 -0.56%
TLS 3.53 -0.56%
TLS 3.53 -0.56%
AGO 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
CGM 0.02 100.00%
CGM 0.02 100.00%
CGM 0.02 100.00%
CGM 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
GMD 0.03 50.00%
GMD 0.03 50.00%
More..
ASX Australia Top Losers Stocks
RRP 0.08 -90.59%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AOK 0.01 -50.00%
GDY 0.01 -50.00%
QSS 0.01 -50.00%
AGJ 0.03 -40.00%
More..

Acrux Ltd (ASX: ACR)

ACR Technical Analysis 5
As on 26th Sep 2017 ACR Share Price closed @ 0.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.28 & Strong Sell for SHORT-TERM with Stoploss of 0.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
ACR Target for September
1st Target up-side 0.3
2nd Target up-side 0.32
3rd Target up-side 0.35
1st Target down-side 0.22
2nd Target down-side 0.2
3rd Target down-side 0.17
ACR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.acrux.com.au
ACR Address
ACR
103-113 Stanley Street
West Melbourne, VIC 3003
Australia
Phone: 61 3 8379 0100
Fax: 61 3 8379 0101
ACR Latest News
Interactive Technical Analysis Chart Acrux Ltd ( ACR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Acrux Ltd
ACR Business Profile
Acrux Limited, a drug delivery company, develops and commercializes a range of patient-preferred and patented pharmaceutical products using its technology to administer proven medicines through the skin. The company’s products include Axiron to treat testosterone deficiency in men; Evamist for menopause symptoms; and Recuvyra pain relief for dogs. Its product under registration comprises Estradiol MDTS for menopause symptoms. The company is also developing Luramist for female HSDD; Nestorone MDTS for contraception; Nicotine MDTS for smoking cessation; and NSAIDs for pain and inflammation. It operates in Australia, accessing international pharmaceutical markets through commercial partners. Acrux was founded in 1998 and is based in West Melbourne, Australia.